Status:

RECRUITING

Nanopore Sequencing in Ophthalmology

Lead Sponsor:

Medical University of Graz

Conditions:

Endophthalmitis

Eligibility:

All Genders

18-99 years

Brief Summary

In this pilot study, the feasibility of the Oxford Nanopore MinION to identify pathogens from vitrectomy samples in eyes with endophthalmitis shall be assessed. The MinION is a low cost commercially a...

Detailed Description

Vitreous samples and anterior chamber taps from eyes with endophthalmitis are taken during routine vitrectomy. The gathered samples are divided in half to undergo routine culture for microbial growth ...

Eligibility Criteria

Inclusion

  • Eyes of patients with endophthalmitis

Exclusion

  • No informed consent possible
  • Participation in other studies

Key Trial Info

Start Date :

April 22 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2027

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05372861

Start Date

April 22 2022

End Date

December 1 2027

Last Update

September 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universitäts Augenklinik Graz

Graz, Styria, Austria, 8036